Neo-adjuvant
This page covers how to assess readiness, educate patients on the “why now” of neoadjuvant treatment, and monitor early toxicities and red flags between visits. You will also find tumour-specific nuances, living well supports, population considerations, and practical recommendations to guide consistent care.
